Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale - Italy
AUTHOR PROFILE
Scopus
Orcid
EARLY ACADEMIC PURSUITS
Dr. Vincenzo Quagliariello embarked on his academic journey by specializing in Clinical Biochemistry and Clinical Pathology at the University of Campania Luigi Vanvitelli. This laid the groundwork for his future endeavors in the medical field.
PROFESSIONAL ENDEAVORS
His professional journey saw him contribute significantly to the field of medical research. He held a fixed-term contract as a "Health Researcher DS6" at the prestigious Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Division of Cardiology, where he made notable contributions to the study of cardiology.
CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIO-ONCOLOGY
Dr. Quagliariello's research focus spans various areas, including biochemistry, clinical pathology, and cardiology. Notably, he has participated as a speaker in numerous national and international congresses since 2011, showcasing his expertise and sharing valuable insights with the scientific community.
IMPACT AND INFLUENCE
His contributions to the field of medical research are underscored by his involvement in the development of innovative medical devices and pharmaceutical formulations aimed at enhancing the efficacy of cancer treatment. Dr. Quagliariello's work has the potential to positively impact patient care and outcomes.
ACADEMIC CITATIONS
Dr. Quagliariello's work has likely garnered attention within the academic community, potentially leading to citations in scholarly literature. His involvement in pioneering research projects and participation in congresses further solidify his standing in the scientific community.
LEGACY AND FUTURE CONTRIBUTIONS
Dr. Quagliariello's legacy lies in his dedication to advancing medical science, particularly in the fields of Cardio-oncology. His innovative patents and contributions to scientific literature lay the foundation for future breakthroughs in cancer treatment and cardiovascular medicine. As he continues his academic and professional journey, he is poised to make even greater contributions to the field, leaving a lasting impact on healthcare and patient outcomes.
NOTABLE PUBLICATIONS
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients. 2024
Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology? 2022 (12)
The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies. 2022 (24)
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin. 2021 (199)
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives. 2021 (40)